1-4 of 4
Kevin D Boyd, MB.BS
Close
Sort by
Journal Articles

Hypermethylation Is A Key Feature of the Transition of Multiple Myeloma to Plasma Cell Leukemia

Brian A Walker, BSc, PhD, Christopher P Wardell, PhD, Kevin D Boyd, MB.BS, Emma M. Smith, PhD, Mette Nyegaard, Maria Teresa Petrucci, MD, Pellegrino Musto, MD, Hans E Johnsen, MD, DMSc, Antonino Neri, MD, Faith E. Davies, MD, Fiona M. Ross, BSc, DPhil, Gareth J Morgan, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 535.
https://doi.org/10.1182/blood.V116.21.535.535
Published: 2010
Journal Articles

The Introduction of Novel Agents Improves Outcomes of Young Patients with Myeloma (MM) Treated with Autologous Stem Cell Transplant (ASCT)

Radovan Saso, MD, MPhil, PhD, Kevin D Boyd, MB.BS, Kabir Mohammed, Ping Wu, Jennifer Treleaven, Faith E. Davies, MD, Gareth J Morgan, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1348.
https://doi.org/10.1182/blood.V116.21.1348.1348
Published: 2010
Journal Articles

Defining Myeloma Patients at High Risk of Developing Bone Disease While on Bisphosphonate Treatment

Ping Wu, Brian A Walker, PhD, Kevin D Boyd, MB.BS, Christopher P Wardell, PhD, David C Johnson, Walter M Gregory, Faith E Davies, Daniel Brewer, Gareth J Morgan, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 782.
https://doi.org/10.1182/blood.V116.21.782.782
Published: 2010
Journal Articles

UTX , a Histone Demethylase, Is Inactivated through Homozygous Deletion, Mutation, and DNA Methylation in Multiple Myeloma.

Brian A Walker, PhD, Paola E. Leone, PhD, Nicholas J Dickens, DPhil, Kevin D Boyd, MB.BS, David Gonzalez, PhD, Faith E Davies, MD, Gareth J Morgan
Journal: Blood
Blood (2009) 114 (22): 1798.
https://doi.org/10.1182/blood.V114.22.1798.1798
Published: 2009